Conmed (CNMD) Tops Q2 EPS by 3c; Raises Outlook

July 31, 2019 4:04 PM

Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.56, $0.03 better than the analyst estimate of $0.53. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found